Imunon, Inc. (IMNN) vs Pulmatrix, Inc. (PULM)

Imunon, Inc. and Pulmatrix, Inc. are both Biotechnology companies. Imunon, Inc. and Pulmatrix, Inc. are of similar size ($5.1M and $5.1M). Pulmatrix, Inc. grew revenue faster over the last twelve months: 6.96% against 0.00%. Across the 15 metrics below, Pulmatrix, Inc. leads on 11 and Imunon, Inc. on 4.

Valuation

Metric IMNN PULM Biotechnology median
P/E n/m n/m 10.60
P/S 8.90 0.65 9.40
P/B 2.30 3.19 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 6.23 0.84 9.02
Earnings yield (450.59%) (79.14%) (32.88%)
Free cash flow yield (341.72%) (84.87%) (23.13%)

Profitability

Metric IMNN PULM Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (641.02%) (111.99%) (51.96%)
Return on assets (123.93%) (85.74%) (46.06%)
Return on invested capital (324.37%) 0.00% 0.00%

Growth

Metric IMNN PULM Biotechnology median
Revenue growth (TTM) 0.00% 6.96% 6.76%
EPS growth (last fiscal year) 59.68% 46.18% 29.88%
Revenue growth, 5-year CAGR 0.00% (0.26%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMNN PULM Biotechnology median
Debt to equity 1.32 0.00 0.00
Current ratio 1.82 4.70 4.97
Net debt to EBITDA 0.63 0.79 1.01

Dividend

Metric IMNN PULM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMNN PULM Biotechnology median
Market cap 5.05m 5.11m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack